Eviti

What Eviti does

Eviti is a web-based healthcare technology product suite that provides clinical decision support and prior authorization for oncology and autoimmune disease treatment plans. It is developed, owned, and operated by NantHealth, Inc. (NASDAQ: NH), a publicly traded healthcare technology company, and is positioned as a B2B platform serving oncologists, autoimmune disease specialists, and health plans in the United States. The product is headquartered in Philadelphia, Pennsylvania, with supporting operations at NantHealth's corporate headquarters in El Segundo, California.

Eviti consists of three core offerings. Eviti Connect for Oncology (connect.eviti.com) and Eviti Connect for Autoimmune Diseases (autoimmuneconnect.eviti.com) are web-based prior-authorization platforms that enable providers to enter prescribed treatment plans online, with the stated objectives of minimizing calls to health plans and reducing denials and appeals. Eviti Advisor (connect.eviti.com/evitiadvisor) is a clinical decision support tool backed by an in-house digital library of thousands of evidence-based treatment regimens and clinical trials across all cancer types and subtypes, with comparison capability across level of evidence, expected outcomes, costs, and toxicities. The platform's clinical content is grounded in NCCN Clinical Practice Guidelines and the NCCN Compendium, which are licensed from the National Comprehensive Cancer Network. The platform is HITRUST CSF certified and NCQA accredited, reflecting compliance with healthcare data security and quality standards.

Eviti operates on a subscription-based, B2B SaaS model. Healthcare providers and their staff access the platform only after registration and authorization by their healthcare organization, submitting Tax ID and NPI credentials. Revenue streams derive from healthcare-provider subscriptions and from health-plan services to process and validate prior authorization requests. Go-to-market is direct enterprise sales, routed through [email protected] and a dedicated phone line, with marketing limited to a product web presence and demonstration videos. Pricing is not publicly disclosed. Named customers are limited to CTCA (Cancer Treatment Centers of America) for Eviti Advisor; broader customer disclosures are not available in the source data.

Name

Eviti

Legal name

NantHealth, Inc.

Website

https://eviti.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Eviti is a healthcare technology product suite, owned by NantHealth, Inc. (NASDAQ: NH), that provides web-based prior authorization and clinical decision support for oncology and autoimmune treatment plans, serving healthcare providers and health plans in the United States.

Ownership category

akta.pro rank

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Provider Subscriptions: Healthcare providers and their staff access Eviti services through authorization from their healthcare organization. The platform is offered as a service subject to terms of use agreements between providers and NantHealth.
2. Health Plan Services: Eviti provides services to health plans to process prior authorization requests, reducing administrative burden and denials/appeals for treatment plans.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Eviti is a web-based healthcare treatment intelligence platform that helps clinicians and health plans with the prior authorization of oncology and autoimmune disease treatment plans. The platform combines an evidence-based clinical decision support tool with a digital library of treatment regimens and clinical trials, integrating NCCN guidelines to enable providers to submit treatment authorization requests online, minimize calls to health plans, and reduce denials and appeals.

Product overview

Eviti is a suite of web-based healthcare products developed and supported by NantHealth, Inc. The product suite consists of three core offerings: Eviti Connect for Oncology (at https://connect.eviti.com) handles prior authorization of oncology treatment plans; Eviti Connect for Autoimmune Diseases (at https://autoimmuneconnect.eviti.com/) manages prior authorization for autoimmune disease treatments; and Eviti Advisor (at https://connect.eviti.com/evitiadvisor) provides clinical decision support with a comprehensive evidence-based treatment library. All products are designed to aid healthcare providers with treatment authorization, clinical decision-making, and reducing administrative burden with health plans.

Differentiator

Problem solved

Functional benefit

Brands

• Eviti Connect for Oncology: A platform for prior authorization of oncology treatment plans available at https://connect.eviti.com.
• Eviti Connect for Autoimmune Diseases
• Eviti Advisor

Products and services

• Eviti Connect for Oncology A web-based platform that enables oncologists and oncology care teams to enter prescribed oncology treatment plans online, submit prior authorization requests to health plans, minimize calls to health plans, and reduce denials and appeals.
• Eviti Connect for Autoimmune Diseases A web-based platform enabling healthcare providers treating autoimmune conditions to submit and manage prior authorization for treatment plans, including biologic and specialty medications, through a streamlined online workflow.
• Eviti Advisor A clinical decision support tool providing a comprehensive independent digital library of evidence-based treatment options and clinical trials, allowing providers to compare treatment details including level of evidence, expected outcomes, costs, and toxicities across thousands of treatment regimens and clinical trials for all cancers and cancer subtypes.

Quantifiable outcome

• Minimize calls to health plans
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• National Comprehensive Cancer Network (NCCN)coreTechnology or IntegrationEviti incorporates NCCN Clinical Practice Guidelines and NCCN Compendium content to provide evidence-based treatment recommendations. The NCCN Guidelines are a statement of consensus regarding accepted approaches to cancer treatment and are updated as new significant data becomes available.
• CTCA (Cancer Treatment Centers of America)coreStrategic or Co-development PartnerCTCA uses Eviti Advisor as their clinical decision support platform for cancer treatment decisions. Eviti provides CTCA with access to a comprehensive library of evidence-based treatment options and clinical trials, enabling comparison of treatment details including level of evidence, expected outcomes, costs, and toxicities.

Scale indicators1 record

Recent moves6 records

Expansion highlights3 records

Direct peers

• Cohere Health: AI-powered prior authorization platform serving both health plans and providers across multiple specialties. Direct competitor to Eviti Connect on the payer-side authorization workflow, with comparable value proposition around reducing denials and appeals.
• eviCore (Carelon Medical Benefits Management): Utilization management and prior authorization services owned by Elevance Health/Carelon. Operates as a broad prior auth vendor across oncology, cardiology, radiology, and other specialties — directly competing with Eviti in oncology and autoimmune prior authorization.
• Infinx Healthcare: Prior authorization and revenue cycle automation platform with deep specialty pharma and oncology exposure. Competes with Eviti on the provider-payer prior auth workflow and shares the same oncology/infusion vertical focus.
• Elsevier ClinicalPath (formerly Via Oncology): Oncology-specific clinical decision support platform providing evidence-based treatment pathways. Direct competitor to Eviti Advisor's evidence-based treatment library value proposition, with comparable NCCN-anchored content and cancer care decision support.

Broad incumbents

• CoverMyMeds (McKesson): Industry-leading electronic prior authorization platform for medications, owned by McKesson. Operates at much greater scale across the pharmacy benefit and specialty medication prior auth workflow that overlaps with Eviti Connect for Autoimmune Diseases.
• NantHealth (parent entity): Publicly-traded parent company (NASDAQ: NH) of Eviti. Provides broader connected care, molecular analysis, and care coordination platforms; Eviti is one product line within NantHealth's portfolio.
• Flatiron Health: Oncology-focused electronic medical record and real-world data platform (Roche subsidiary). Overlaps with Eviti on oncology decision support and the intersection of treatment pathways with structured clinical data.
• Surescripts: Health information network operating e-prescribing and prior authorization routing infrastructure. Competes in the specialty medication and ePA workflow space adjacent to Eviti Connect for Autoimmune Diseases.

Emerging players

• Tempus Labs: AI-powered precision medicine and oncology decision support company. Adjacent to Eviti Advisor on the oncology evidence and clinical decision support axis, with deeper AI/ML capabilities but a different primary buyer profile.
• Avizia (now part of American Well): Telehealth and care coordination platform; partial overlap with the connected care and clinical workflow automation value proposition that underlies Eviti's payer-provider integration model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/eviti_empowers

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eviti